ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 71 filers reported holding ADAGIO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $11,097,900 | 12.55% |
| Alphabet Inc. | 5,680,785 | $6,816,942 | 0.38% |
| 683 Capital Management, LLC | 3,400,000 | $4,080,000 | 0.30% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,325 | 0.29% |
| Slate Path Capital LP | 3,735,000 | $4,482,000 | 0.21% |
| Orbimed Advisors | 5,270,400 | $6,324,480 | 0.12% |
| Redmile Group, LLC | 1,440,725 | $1,728,870 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $480,000 | 0.07% |
| MAVERICK CAPITAL LTD | 1,887,527 | $2,265,032 | 0.06% |
| Triatomic Management LP | 25,800 | $30,960 | 0.02% |